No Data
No Data
Quantum BioPharma Ltd. to Host Business Update Conference Call on May 6, 2025
Press Release: Quantum Biopharma Announces Advocate Against Naked Short Selling and Stock Manipulation, Kevin Malone Appointed as Board Advisor
Press Release: Quantum Biopharma Announces Closing of Final $2.42 Million Tranche of $5 Million Total Financing on Improved Terms
Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern
Quantum BioPharma Ltd: MDA EN
Quantum BioPharma Ltd: AUDITED ANNUAL FINANCIAL STATEMENTS EN
I Am 102927471 :